Last update 01 Nov 2024

Atumelnant

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mechanism
ACTH receptor antagonists(Melanocortin receptor 2 antagonists)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC33H42F3N5O3
InChIKeyQJRFBKYETDVAJQ-ZEQKJWHPSA-N
CAS Registry2392970-97-5

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cushing SyndromePhase 2
US
12 Oct 2023
Ectopic ACTH SyndromePhase 2
US
12 Oct 2023
Pituitary ACTH HypersecretionPhase 2
US
12 Oct 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
AR
03 Jul 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
GB
03 Jul 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
DE
03 Jul 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
BR
03 Jul 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
IT
03 Jul 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
US
03 Jul 2023
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase DeficiencyPhase 2
IN
03 Jul 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
5
pcrwzzgspr(jozfagkakd) = 252 mcg (99-293) vs 24 mcg (3.9-51); adylaverdo (dxlckqkydl )
Positive
03 Jun 2024
Phase 1
4
ssysxotqji(ztywzvumaa) = rapid and profound androstenedione reductions within two weeks which were maintained for the duration of therapy, androstenedione reductions ranged from 74% to 99%. ohecaizrvy (gvjovnvevy )
Positive
22 May 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free